A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Toray Industries, Inc
Instituto do Cancer do Estado de São Paulo
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
University Hospital, Geneva